TOFACITINIB CITRATE | A219395 | SPECGX LLC
2 strengths0 unique patents0 unique exclusivities
Reference Listed Drug: XELJANZ(TE code: AB) Products (2)
Sort:
No patent or exclusivity listings for this strength.
ADDED7/1/2026
Tofacitinib citrate (SPECGX LLC, NDA 219395) received FDA approval for a new product formulation or indication.
ADDED7/1/2026
TOFACITINIB CITRATE (tofacitinib citrate) NDA 219395 Supplement 002 was added to the FDA Orange Book product listing.